标题
Lung Cancer: Understanding Its Molecular Pathology and the 2015 WHO Classification
作者
关键词
-
出版物
Frontiers in Oncology
Volume 7, Issue -, Pages -
出版商
Frontiers Media SA
发表日期
2017-08-28
DOI
10.3389/fonc.2017.00193
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- Tumor B7-H3 (CD276) expression and smoking history in relation to lung adenocarcinoma prognosis
- (2017) Kentaro Inamura et al. LUNG CANCER
- Relationship of tumor PD-L1 expression withEGFRwild-type status and poor prognosis in lung adenocarcinoma
- (2016) Kentaro Inamura et al. JAPANESE JOURNAL OF CLINICAL ONCOLOGY
- Small Cell Lung Cancer Screen of Oncology Drugs, Investigational Agents, and Gene and microRNA Expression
- (2016) Eric Polley et al. JNCI-Journal of the National Cancer Institute
- KRAS and NKX2-1 Mutations in Invasive Mucinous Adenocarcinoma of the Lung
- (2016) David H. Hwang et al. Journal of Thoracic Oncology
- Aggressive tumor microenvironment of solid predominant lung adenocarcinoma subtype harboring with epidermal growth factor receptor mutations
- (2016) Koichi Saruwatari et al. LUNG CANCER
- MicroRNA expression profiles and clinicopathological implications in lung adenocarcinoma according to EGFR, KRAS, and ALK status
- (2016) Hyojin Kim et al. Oncotarget
- Small Cell Lung Cancer Screen of Oncology Drugs, Investigational Agents, and Gene and microRNA Expression
- (2016) Eric Polley et al. JNCI-Journal of the National Cancer Institute
- MicroRNA In Lung Cancer: Novel Biomarkers and Potential Tools for Treatment
- (2016) Kentaro Inamura et al. Journal of Clinical Medicine
- Differential miRNA-Expression as an Adjunctive Diagnostic Tool in Neuroendocrine Tumors of the Lung
- (2016) Melanie Demes et al. Cancers
- Recent Advances in Immunotherapy in Metastatic NSCLC
- (2016) Pranshu Bansal et al. Frontiers in Oncology
- Recent Advances in Targetable Therapeutics in Metastatic Non-Squamous NSCLC
- (2016) Pranshu Bansal et al. Frontiers in Oncology
- Notch Signaling in Neuroendocrine Tumors
- (2016) Judy S. Crabtree et al. Frontiers in Oncology
- MicroRNA Targeting to Modulate Tumor Microenvironment
- (2016) Praneeth R. Kuninty et al. Frontiers in Oncology
- Export of microRNAs: A Bridge between Breast Carcinoma and Their Neighboring Cells
- (2016) Devashree Jahagirdar et al. Frontiers in Oncology
- Global cancer statistics, 2012
- (2015) Lindsey A. Torre et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Unique Genetic and Survival Characteristics of Invasive Mucinous Adenocarcinoma of the Lung
- (2015) Hyo Sup Shim et al. Journal of Thoracic Oncology
- Comprehensive genomic profiles of small cell lung cancer
- (2015) Julie George et al. NATURE
- Mutational landscape determines sensitivity to PD-1 blockade in non-small cell lung cancer
- (2015) N. A. Rizvi et al. SCIENCE
- SF3A1 and pancreatic cancer: new evidence for the association of the spliceosome and cancer
- (2015) Jing Tian et al. Oncotarget
- MiRNA-10a is upregulated in NSCLC and may promote cancer by targeting PTEN
- (2015) Tao Yu et al. Oncotarget
- MicroRNA profiling of primary pulmonary enteric adenocarcinoma in members from the same family reveals some similarities to pancreatic adenocarcinoma—a step towards personalized therapy
- (2015) Ingrid Garajová et al. Clinical Epigenetics
- HABP2 is a Novel Regulator of Hyaluronan-Mediated Human Lung Cancer Progression
- (2015) Tamara Mirzapoiazova et al. Frontiers in Oncology
- RET-rearranged non-small-cell lung carcinoma: a clinicopathological and molecular analysis
- (2014) K Tsuta et al. BRITISH JOURNAL OF CANCER
- Druggable Oncogene Fusions in Invasive Mucinous Lung Adenocarcinoma
- (2014) T. Nakaoku et al. CLINICAL CANCER RESEARCH
- A MicroRNA Cluster at 14q32 Drives Aggressive Lung Adenocarcinoma
- (2014) E. Nadal et al. CLINICAL CANCER RESEARCH
- Comprehensive molecular profiling of lung adenocarcinoma
- (2014) Eric A. Collisson et al. NATURE
- CD74-NRG1 Fusions in Lung Adenocarcinoma
- (2014) L. Fernandez-Cuesta et al. Cancer Discovery
- ROS1-Rearranged Lung Cancer
- (2013) Akihiko Yoshida et al. AMERICAN JOURNAL OF SURGICAL PATHOLOGY
- Oncogenic and drug-sensitive NTRK1 rearrangements in lung cancer
- (2013) Aria Vaishnavi et al. NATURE MEDICINE
- Comprehensive genomic analysis identifies SOX2 as a frequently amplified gene in small-cell lung cancer
- (2012) Charles M Rudin et al. NATURE GENETICS
- Integrative genome analyses identify key somatic driver mutations of small-cell lung cancer
- (2012) Martin Peifer et al. NATURE GENETICS
- KIF5B-RET fusions in lung adenocarcinoma
- (2012) Takashi Kohno et al. NATURE MEDICINE
- RET, ROS1 and ALK fusions in lung cancer
- (2012) Kengo Takeuchi et al. NATURE MEDICINE
- miR-375 Is Activated by ASH1 and Inhibits YAP1 in a Lineage-Dependent Manner in Lung Cancer
- (2011) E. Nishikawa et al. CANCER RESEARCH
- International Association for the Study of Lung Cancer/American Thoracic Society/European Respiratory Society International Multidisciplinary Classification of Lung Adenocarcinoma
- (2011) William D. Travis et al. Journal of Thoracic Oncology
- p40 (ΔNp63) is superior to p63 for the diagnosis of pulmonary squamous cell carcinoma
- (2011) Justin A Bishop et al. MODERN PATHOLOGY
- Clinical Features and Outcome of Patients With Non–Small-Cell Lung Cancer Who Harbor EML4-ALK
- (2009) Alice T. Shaw et al. JOURNAL OF CLINICAL ONCOLOGY
- EML4-ALK lung cancers are characterized by rare other mutations, a TTF-1 cell lineage, an acinar histology and young onset
- (2009) Kentaro Inamura et al. MODERN PATHOLOGY
- EML4-ALK Fusion Is Linked to Histological Characteristics in a Subset of Lung Cancers
- (2008) Kentaro Inamura et al. Journal of Thoracic Oncology
- Correlation between morphology and EGFR mutations in lung adenocarcinomas
- (2008) Hironori Ninomiya et al. LUNG CANCER
Become a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get StartedAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started